Atrium Therapeutics, Inc. (RNA)

CIK 2093101 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Atrium Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 2026SCHEDULE 13G/A0000080255-26-000590
Aug 14, 2026SCHEDULE 13G0000902664-26-003500
Aug 14, 2026SCHEDULE 13G/A0001231919-26-000917
Aug 13, 20268-K0001193125-26-349482
Aug 13, 202610-Q0001193125-26-349488
Jul 27, 2026SCHEDULE 13G/A0002012383-26-002192
Jul 14, 20268-K0001193125-26-303393
May 15, 2026SCHEDULE 13G0001346824-26-000145
May 14, 202610-Q0001193125-26-224243
May 14, 20268-K0001193125-26-224238
Apr 27, 2026SCHEDULE 13G0002012383-26-001673
Apr 22, 202640001193125-26-170914
Apr 22, 202640001193125-26-170907
Apr 22, 202640001193125-26-170963
Apr 22, 202640001193125-26-170960
Apr 22, 202640001193125-26-170964
Apr 22, 202640001193125-26-170906
Apr 17, 2026S-80001193125-26-161513
Apr 8, 2026SCHEDULE 13G0000080255-26-000316
Mar 2, 202640001193125-26-085919
Mar 2, 202640001193125-26-085921
Mar 2, 202640001193125-26-085922
Mar 2, 202640001193125-26-085918
Mar 2, 202640001193125-26-085920
Feb 27, 20268-K0001193125-26-083227